Stem Cell Transplantation | Malignant Lymphoma | Risk Factors for Secondary Myelodysplasia & AML

Purpose: To identify a patient with malignant lymphoma undergoing autologous stem cell transplantation (SCT) for risk of secondary myelodysplasia and/or AML.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient about to undergo autologous stem cell transplan-tation for malignant lymphoma?

Yes

Number of prior chemotherapy regimens

Has the patient previously received radiation therapy?

Yes

Number of days of pheresis required to harvest enough stem cells

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for secondary myelodysplasia

The risk of secondary myelodysplasia is

Should the patient be closely monitored for signs of myelodysplasia?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Criteria For Diagnosis
Complications
- Risk of Lung Cancer Following Therapy for Hodgkin's Disease

Monitoring

Response To Therapy
- Therapy-Related Acute Myeloid Leukemia
- Radiation Exposure | Carcinomas of Kidney & Urinary Tract
Adverse Effects
- Radiation Exposure | Carcinomas of Kidney & Urinary Tract
Disease Progression
- Therapy-Related Acute Myeloid Leukemia
Comorbid Conditions
- Stewart-Treves Syndrome

Specialty

Hematology Oncology
Surgery, general

Objective

risk factors
criteria for diagnosis

ICD-10

C92.0 - Acute myeloblastic leukaemia [AML]

Info

Purpose: To identify a patient with malignant lymphoma undergoing autologous stem cell transplantation (SCT) for risk of secondary myelodysplasia and/or AML.

Specialty: Hematology Oncology, Surgery, general

Objective: risk factors, criteria for diagnosis

ICD-10: C92.0,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path